Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Rubella-Virus Hemagglutination-Inhibition Test
1967335 citationsGeorge L. Stewart, Paul D. Parkman et al.New England Journal of Medicineprofile →
Citations per year, relative to Harry M. Meyer Harry M. Meyer (= 1×)
peers
Dorothy M. Horstmann
Countries citing papers authored by Harry M. Meyer
Since
Specialization
Citations
This map shows the geographic impact of Harry M. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry M. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry M. Meyer more than expected).
This network shows the impact of papers produced by Harry M. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry M. Meyer. The network helps show where Harry M. Meyer may publish in the future.
Co-authorship network of co-authors of Harry M. Meyer
This figure shows the co-authorship network connecting the top 25 collaborators of Harry M. Meyer.
A scholar is included among the top collaborators of Harry M. Meyer based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Harry M. Meyer. Harry M. Meyer is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Sencer, David J., H. Bruce Dull, Elizabeth Barrett‐Connor, et al.. (2015). BCG Vaccines for Tuberculosis. American Review of Respiratory Disease.
2.
Mortimer, Edward A., Vincent A. Fulginiti, Philip A. Brunell, et al.. (1980). Revised Recommendations on Rubella Vaccine. PEDIATRICS. 65(6). 1182–1184.8 indexed citations
3.
Petricciani, John C., Harry M. Meyer, Paul D. Parkman, & Hope E. Hopps. (1977). Session I—The Science and Control of Biologicals: Changes in Technology of Vaccine Research, Development, and Control. Bulletin of the World Health Organization. 55. 45.
Meyer, Harry M. & Paul D. Parkman. (1967). RUDELLA. The American Journal of the Medical Sciences. 253(3). 349–373.14 indexed citations
13.
Stewart, George L., et al.. (1967). Rubella-Virus Hemagglutination-Inhibition Test. New England Journal of Medicine. 276(10). 554–557.335 indexed citations breakdown →
14.
Parkman, Paul D., Harry M. Meyer, Ruth L. Kirschstein, & Hope E. Hopps. (1966). Attenuated Rubella Virus. New England Journal of Medicine. 275(11). 569–574.111 indexed citations
15.
Meyer, Harry M., et al.. (1964). RESPONSE OF VOLTA CHILDREN TO LIVE ATTENUATED MEASLES VIRUS VACCINE.. PubMed. 30. 769–81.13 indexed citations
16.
Meyer, Harry M., et al.. (1964). RESPONSE OF VOLTA CHILDREN TO JET INOCULATION OF COMBINED LIVE MEASLES, SMALLPOX AND YELLOW FEVER VACCINES.. PubMed. 30. 783–94.36 indexed citations
17.
Meyer, Harry M.. (1962). Ecology of Measles in Monkeys. Archives of Pediatrics and Adolescent Medicine. 103(3). 307–307.37 indexed citations
18.
Meyer, Harry M., Hope E. Hopps, Nancy G. Rogers, et al.. (1962). Studies on simian virus 40.. PubMed. 88. 796–806.53 indexed citations
19.
Meyer, Harry M., Richard T. Johnson, Irving P. Crawford, Harry E. Dascomb, & Nancy G. Rogers. (1960). Central nervous system syndromes of “viral” etiology. The American Journal of Medicine. 29(2). 334–347.217 indexed citations
20.
Meyer, Harry M., et al.. (1959). Cesarean hysterectomy. American Journal of Obstetrics and Gynecology. 77(6). 1240–1244.9 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.